These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30223707)

  • 1. Intestinal macrophages in mucosal immunity and their role in systemic lupus erythematosus disease.
    Pan F; Tang W; Zhou Z; Gilkeson G; Lang R; Jiang W
    Lupus; 2018 Oct; 27(12):1898-1902. PubMed ID: 30223707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased miR-4512 Levels in Monocytes and Macrophages of Individuals With Systemic Lupus Erythematosus Contribute to Innate Immune Activation and Neutrsophil NETosis by Targeting TLR4 and CXCL2.
    Yang B; Huang X; Xu S; Li L; Wu W; Dai Y; Ge MX; Yuan L; Cao W; Yang M; Wu Y; Deng D
    Front Immunol; 2021; 12():756825. PubMed ID: 34721432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte and macrophage abnormalities in systemic lupus erythematosus.
    Li Y; Lee PY; Reeves WH
    Arch Immunol Ther Exp (Warsz); 2010 Oct; 58(5):355-64. PubMed ID: 20676786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virgin olive oil and its phenol fraction modulate monocyte/macrophage functionality: a potential therapeutic strategy in the treatment of systemic lupus erythematosus.
    Aparicio-Soto M; Montserrat-de la Paz S; Sanchez-Hidalgo M; Cardeno A; Bermudez B; Muriana FJG; Alarcon-de-la-Lastra C
    Br J Nutr; 2018 Sep; 120(6):681-692. PubMed ID: 30060774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of SLE: functional relevance for monocytes/macrophages in disease.
    Byrne JC; Ní Gabhann J; Lazzari E; Mahony R; Smith S; Stacey K; Wynne C; Jefferies CA
    Clin Dev Immunol; 2012; 2012():582352. PubMed ID: 23227085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal.
    Katsiari CG; Liossis SN; Sfikakis PP
    Semin Arthritis Rheum; 2010 Jun; 39(6):491-503. PubMed ID: 19147182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
    Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
    Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.
    Zhou Z; Ding M; Huang L; Gilkeson G; Lang R; Jiang W
    Clin Immunol; 2016 Dec; 173():81-86. PubMed ID: 27620642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage subpopulations in systemic lupus erythematosus.
    Orme J; Mohan C
    Discov Med; 2012 Feb; 13(69):151-8. PubMed ID: 22369974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis.
    Hirose S; Lin Q; Ohtsuji M; Nishimura H; Verbeek JS
    Int Immunol; 2019 Oct; 31(11):687-696. PubMed ID: 31063541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate Immune Cells' Contribution to Systemic Lupus Erythematosus.
    Herrada AA; Escobedo N; Iruretagoyena M; Valenzuela RA; Burgos PI; Cuitino L; Llanos C
    Front Immunol; 2019; 10():772. PubMed ID: 31037070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus.
    Tumurkhuu G; Montano E; Jefferies C
    Curr Rheumatol Rep; 2019 Jul; 21(9):46. PubMed ID: 31338604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte (macrophage)-specific antibodies in patients with systemic lupus erythematosus (SLE).
    Shirakawa F; Yamashita U; Suzuki H
    J Clin Immunol; 1987 Mar; 7(2):121-9. PubMed ID: 3571434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus.
    Davis LS; Hutcheson J; Mohan C
    J Interferon Cytokine Res; 2011 Oct; 31(10):781-9. PubMed ID: 21787222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?
    Wu HY
    Clin Immunol; 2009 Feb; 130(2):111-22. PubMed ID: 18938110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus.
    Kavai M; Szegedi G
    Autoimmun Rev; 2007 Aug; 6(7):497-502. PubMed ID: 17643939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: A crucial role for aryl hydrocarbon receptor.
    Mohammadi S; Memarian A; Sedighi S; Behnampour N; Yazdani Y
    Autoimmunity; 2018 Aug; 51(5):199-209. PubMed ID: 30289282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of the immune system in systemic lupus erythematosus.
    Ramanujam M; Davidson A
    Expert Rev Mol Med; 2008 Jan; 10():e2. PubMed ID: 18205972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.